About Dana Kelly, PhD

Dr. Dana Kelly is a Clinical Neuropsychologist at the MGH Psychology Assessment Center (PAC), Instructor at Harvard Medical School, and a Licensed Clinical Psychologist in Massachusetts and Rhode Island.Dr. Kelly performs neuropsychological evaluations of adults, including extensive work with the older adult (age 65+) population. She specializes in neurodegenerative disorders, including Alzheimer's disease, Lewy body dementia, and frontotemporal disorders. She also has clinical expertise in normal pressure hydrocephalus, cerebrovascular disease (e.g., stroke), epilepsy, multiple sclerosis, traumatic brain injury, functional neurological disorders, and other neuropsychiatric conditions.Dr. Kelly?s current research aims to better understand medication effects and adherence in older adults with cognitive impairment.Dr. Kelly completed undergraduate studies at the University of Michigan-Ann Arbor. She earned an M.S. and Ph.D. in clinical psychology with specialization in neuropsychology from Rosalind Franklin University of Medicine and Science. Her clinical training included a neuropsychology residency at Rush University Medical Center and a postdoctoral fellowship in clinical neuropsychology at Brown University Warren Alpert Medical School.

Clinical Interests:

Treats:

Locations

Mass General Psychology Assessment Center
One Bowdoin Square
7th Floor
Boston, MA 02114
Phone: 617-726-3647

Medical Education

  • Residency, Rush University Medical Center
  • Fellowship, Warren Alpert Medical School of Brown University, Rhode Island Hospital & Miriam Hospital

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Publications

  • Margolis, S., Kelly, D.A., Daiello, L.A., Davis, J., Tremont, G., Pillemer, S., Denby, C. (2020). Anticholinergic/sedative drug burden and subjective cognitive decline in older adults at risk of Alzheimer?s disease. The Journals of Gerontology: Medical Sciences. DOI: 10.1093/gerona/glaa222{line break}Abraham, M., Seidenberg, M., Kelly, D.A., Nielson, K.A., Woodard, J.L, Smith, J.C., Durgerian, S., & Rao, S.M. (2020). Episodic memory and hippocampal volume predict five-year MCI conversion in healthy APOE e4 carriers. Journal of the International Neuropsychology Society, 26(7), 733-738. DOI:10.1017/S1355617720000181{line break}Kelly, D.A., Seidenberg, M., Reiter, K., Nielson, K.A., Woodard, J.L., Smith, J.C., Durgerian, S., & Rao, S.M. (2018). Differential 5-year brain atrophy rates in cognitively declining and stable APOE-e4 elders. Neuropsychology, 32(6), 647-653. DOI: 10.1037/neu0000444{line break}Reiter, K., Nielson, K.A., Durgerian, S., Woodard, J.L., Smith J.C., Seidenberg, M., Kelly, D.A., & Rao, S.M. (2017). Five-year longitudinal brain volume change in healthy elders at genetic risk for Alzheimer?s disease. Journal of Alzheimer?s Disease, 55(4), 1363-1377. DOI: 10.3233/JAD-160504

Reviews: Comments and Ratings